296 related articles for article (PubMed ID: 29177796)
1. Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases.
Markovic BS; Kanjevac T; Harrell CR; Gazdic M; Fellabaum C; Arsenijevic N; Volarevic V
Stem Cell Rev Rep; 2018 Apr; 14(2):153-165. PubMed ID: 29177796
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review.
Ko JZ; Johnson S; Dave M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33440772
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases.
Che Z; Ye Z; Zhang X; Lin B; Yang W; Liang Y; Zeng J
Front Immunol; 2022; 13():952071. PubMed ID: 35990688
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease.
Mao F; Tu Q; Wang L; Chu F; Li X; Li HS; Xu W
Oncotarget; 2017 Jun; 8(23):38008-38021. PubMed ID: 28402942
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stem Cell as a Potential Therapeutic for Inflammatory Bowel Disease- Myth or Reality?
Adak S; Mukherjee S; Sen D
Curr Stem Cell Res Ther; 2017; 12(8):644-657. PubMed ID: 28914206
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose-Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model.
Soontararak S; Chow L; Johnson V; Coy J; Wheat W; Regan D; Dow S
Stem Cells Transl Med; 2018 Jun; 7(6):456-467. PubMed ID: 29635868
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell therapy for inflammatory bowel diseases: promise and challenge.
Ke C; Biao H; Qianqian L; Yunwei S; Xiaohua J
Curr Stem Cell Res Ther; 2015; 10(6):499-508. PubMed ID: 26018234
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy.
Saadh MJ; Mikhailova MV; Rasoolzadegan S; Falaki M; Akhavanfar R; Gonzáles JLA; Rigi A; Kiasari BA
Eur J Med Res; 2023 Jan; 28(1):47. PubMed ID: 36707899
[TBL] [Abstract][Full Text] [Related]
9. Targeting improves MSC treatment of inflammatory bowel disease.
Ko IK; Kim BG; Awadallah A; Mikulan J; Lin P; Letterio JJ; Dennis JE
Mol Ther; 2010 Jul; 18(7):1365-72. PubMed ID: 20389289
[TBL] [Abstract][Full Text] [Related]
10. Potential methods for improving the efficacy of mesenchymal stem cells in the treatment of inflammatory bowel diseases.
Zhang X; Wang S; Ding X; Guo J; Tian Z
Scand J Immunol; 2020 Sep; 92(3):e12897. PubMed ID: 32443180
[TBL] [Abstract][Full Text] [Related]
11. Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases.
Grégoire C; Lechanteur C; Briquet A; Baudoux É; Baron F; Louis E; Beguin Y
Aliment Pharmacol Ther; 2017 Jan; 45(2):205-221. PubMed ID: 27878827
[TBL] [Abstract][Full Text] [Related]
12. Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn's disease - review of pathomechanism and existing clinical data.
Bor R; Fábián A; Farkas K; Molnár T; Szepes Z
Expert Opin Biol Ther; 2018 Jul; 18(7):737-745. PubMed ID: 29939815
[TBL] [Abstract][Full Text] [Related]
13. A phase IB/IIA study of remestemcel-L, an allogeneic bone marrow-derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: an interim analysis.
Lightner AL; Dadgar N; Matyas C; Elliott K; Fulmer C; Khaitan N; Ream J; Nachand D; Steele SR
Colorectal Dis; 2022 Nov; 24(11):1358-1370. PubMed ID: 35767384
[TBL] [Abstract][Full Text] [Related]
14. Current Research and Use of Mesenchymal Stem Cells in the Therapy of Autoimmune Diseases.
Chen Y; Yu Q; Hu Y; Shi Y
Curr Stem Cell Res Ther; 2019; 14(7):579-582. PubMed ID: 31729289
[TBL] [Abstract][Full Text] [Related]
15. Cytokine Mixtures Mimicking the Local Milieu in Patients with Inflammatory Bowel Disease Impact Phenotype and Function of Mesenchymal Stromal Cells.
Barnhoorn MC; van der Meulen-de Jong AE; Schrama ECLM; Plug LG; Verspaget HW; Fibbe WE; van Pel M; Hawinkels LJAC; Schepers K
Stem Cells Transl Med; 2022 Sep; 11(9):932-945. PubMed ID: 35984079
[TBL] [Abstract][Full Text] [Related]
16. The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study.
Salmenkari H; Laitinen A; Forsgård RA; Holappa M; Lindén J; Pasanen L; Korhonen M; Korpela R; Nystedt J
Cytotherapy; 2019 Feb; 21(2):175-188. PubMed ID: 30611671
[TBL] [Abstract][Full Text] [Related]
17. Investigating cell therapy for inflammatory bowel disease.
Okamoto R; Watanabe M
Expert Opin Biol Ther; 2016 Aug; 16(8):1015-23. PubMed ID: 27113391
[TBL] [Abstract][Full Text] [Related]
18. Canine adipose tissue-derived mesenchymal stem cells pre-treated with TNF-alpha enhance immunomodulatory effects in inflammatory bowel disease in mice.
Song WJ; Li Q; Ryu MO; Nam A; An JH; Jung YC; Ahn JO; Youn HY
Res Vet Sci; 2019 Aug; 125():176-184. PubMed ID: 31247473
[TBL] [Abstract][Full Text] [Related]
19. Current status of mesenchymal stem cell therapy and bone marrow transplantation in IBD.
Ricart E
Dig Dis; 2012; 30(4):387-91. PubMed ID: 22796802
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem/stromal cell therapy for inflammatory bowel disease: an updated review with maintenance of remission.
Dave M; Jaiswal P; Cominelli F
Curr Opin Gastroenterol; 2017 Jan; 33(1):59-68. PubMed ID: 28134690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
